Radiotherapy options.
Yazid BELKACEMI
Radiotherapist, Créteil, France
What are the options in HER2 postive breast cancer treatments are we moving to t-DXd in first line?
Hassan GHAZAL
oncologist, Dubai
How do you foresee the evolution of screening program in UAE?
Asiya Maheen KHAN
radiologist, Abu Dhabi, EAU
Comment améliorer les stratégies thérapeutiques en radiothérapie des carcinomes in situ dans les sous groupes à bas risque ?
Yazid BELKACEMI
Radiotherapeute, Paris, France
Premalignant lesions: When to avoid open surgery?
Foucauld CHAMMING’S